Transplant International (Jun 2024)
Prevention and Rehabilitation After Heart Transplantation: A Clinical Consensus Statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a Section of ESOT
- Maria Simonenko,
- Dominique Hansen,
- Dominique Hansen,
- Josef Niebauer,
- Maurizio Volterrani,
- Stamatis Adamopoulos,
- Cristiano Amarelli,
- Marco Ambrosetti,
- Stefan D. Anker,
- Antonio Bayes-Genis,
- Tuvia Ben Gal,
- T. Scott Bowen,
- Francesco Cacciatore,
- Giuseppe Caminiti,
- Elena Cavarretta,
- Elena Cavarretta,
- Ovidiu Chioncel,
- Ovidiu Chioncel,
- Andrew J. S. Coats,
- Alain Cohen-Solal,
- Flavio D’Ascenzi,
- Carmen de Pablo Zarzosa,
- Andreas B. Gevaert,
- Andreas B. Gevaert,
- Finn Gustafsson,
- Hareld Kemps,
- Hareld Kemps,
- Loreena Hill,
- Tiny Jaarsma,
- Tiny Jaarsma,
- Ewa Jankowska,
- Emer Joyce,
- Emer Joyce,
- Nicolle Krankel,
- Mitja Lainscak,
- Lars H. Lund,
- Brenda Moura,
- Brenda Moura,
- Kari Nytrøen,
- Elena Osto,
- Elena Osto,
- Massimo Piepoli,
- Massimo Piepoli,
- Luciano Potena,
- Amina Rakisheva,
- Amina Rakisheva,
- Giuseppe Rosano,
- Gianluigi Savarese,
- Petar M. Seferovic,
- David R. Thompson,
- Thomas Thum,
- Emeline M. Van Craenenbroeck,
- Emeline M. Van Craenenbroeck
Affiliations
- Maria Simonenko
- Cardiopulmonary Exercise Test Research Department, Heart Transplantation Outpatient Department, V. A. Almazov National Medical Research Centre, St. Petersburg, Russia
- Dominique Hansen
- REVAL and BIOMED Rehabilitation Research Center, Hasselt University, Hasselt, Belgium
- Dominique Hansen
- Heart Centre Hasselt, Jessa Hospital, Hasselt, Belgium
- Josef Niebauer
- University Institute of Sports Medicine, Prevention and Rehabilitation, Paracelsus Medical University, Salzburg, Austria
- Maurizio Volterrani
- Cardio-Pulmonary Department, IRCCS San Raffaele Roma, Rome, Italy
- Stamatis Adamopoulos
- Heart Failure and Heart Transplantation Unit, Onassis Cardiac Surgery Center, Athens, Greece
- Cristiano Amarelli
- Department of Cardiac Surgery and Transplants, Monaldi Hospital, Azienda dei Colli, Naples, Italy
- Marco Ambrosetti
- Cardiovascular Rehabilitation Unit, ASST Crema, Santa Marta Hospital, Rivolta D’Adda, Italy
- Stefan D. Anker
- Department of Cardiology (CVK), Berlin Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) Partner Site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany
- Antonio Bayes-Genis
- 0University Hospital Germans Trias and Pujol de Badalona, Badalona, Spain
- Tuvia Ben Gal
- 1Heart Failure Unit, Cardiology Department, Rabin Medical Center, Petah Tikva and Sackler, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
- T. Scott Bowen
- 2School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom
- Francesco Cacciatore
- 3Department of Translational Medicine, University of Naples “Federico II”, Naples, Italy
- Giuseppe Caminiti
- Cardio-Pulmonary Department, IRCCS San Raffaele Roma, Rome, Italy
- Elena Cavarretta
- 4Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy
- Elena Cavarretta
- 5Mediterranea Cardiocentro, Naples, Italy
- Ovidiu Chioncel
- 6Emergency Institute for Cardiovascular Diseases “Prof. C. C. Iliescu”, Bucharest, Romania
- Ovidiu Chioncel
- 7University of Medicine Carol Davila, Bucharest, Romania
- Andrew J. S. Coats
- 8Heart Research Institute, Sydney, NSW, Australia
- Alain Cohen-Solal
- 9Cardiology Department, University of Paris, INSERM UMRS-942, Hopital Lariboisiere, AP-HP, Paris, France
- Flavio D’Ascenzi
- 0Division of Cardiology, Department of Medical Biotechnologies, University of Siena, Siena, Italy
- Carmen de Pablo Zarzosa
- 1Department of Cardiology, Ramón y Cajal University Hospital, Madrid, Spain
- Andreas B. Gevaert
- 2Research Group Cardiovascular Diseases, Genetics, Pharmacology and Physiopathology of Heart, Blood Vessels and Skeleton (GENCOR) Department, University of Antwerp, Antwerp, Belgium
- Andreas B. Gevaert
- 3Department of Cardiology, Antwerp University Hospital, Edegem, Belgium
- Finn Gustafsson
- 4Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
- Hareld Kemps
- 5Department of Cardiology, Maxima Medical Centre, Eindhoven, Netherlands
- Hareld Kemps
- 6Department of Industrial Design, Eindhoven University of Technology, Eindhoven, Netherlands
- Loreena Hill
- 7School of Nursing and Midwifery, Queen’s University Belfast, Belfast, United Kingdom
- Tiny Jaarsma
- 8Department of Health, Medicine and Caring Science, Linköping University, Linköping, Sweden
- Tiny Jaarsma
- 9Julius Center, University Medical Center Utrecht, Utrecht, Netherlands
- Ewa Jankowska
- 0Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland
- Emer Joyce
- 1Department of Cardiology, Mater University Hospital, Dublin, Ireland
- Emer Joyce
- 2School of Medicine, University College Dublin, Dublin, Ireland
- Nicolle Krankel
- 3Universitätsmedizin Berlin Campus Benjamin Franklin Klinik für Kardiologie Charite, Berlin, Germany
- Mitja Lainscak
- 4General Hospital Murska Sobota, Murska Sobota, Slovenia
- Lars H. Lund
- 5Department of Medicine, Karolinska Institutet and Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden
- Brenda Moura
- 6Armed Forces Hospital, Porto, Portugal
- Brenda Moura
- 7Centre for Health Technologies and Services Research, Faculty of Medicine of University of Porto, Porto, Portugal
- Kari Nytrøen
- 8Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway
- Elena Osto
- 9Division of Physiology and Pathophysiology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz, Graz, Austria
- Elena Osto
- 0Vetsuisse Faculty, University of Zurich, Zurich, Switzerland
- Massimo Piepoli
- 1Dipartimento Scienze Biomediche per la Salute, Universita’ Degli Studi di Milan, Milan, Italy
- Massimo Piepoli
- 2Cardiologia Universitaria, IRCCS Policlinico San Donato, Milan, Italy
- Luciano Potena
- 3University Hospital of Bologna, Bologna, Italy
- Amina Rakisheva
- 4Department of Cardiology, Scientific Institution of Cardiology and Internal Diseases, Almaty, Kazakhstan
- Amina Rakisheva
- 5Department of Cardiology, Kapshagai City Hospital, Almaty, Kazakhstan
- Giuseppe Rosano
- 6St. George’s Hospital NHS Trust University of London, London, United Kingdom
- Gianluigi Savarese
- 7Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
- Petar M. Seferovic
- 8Faculty of Medicine and Heart Failure Center, University of Belgrade, Belgrade University Medical Center, Belgrade, Serbia
- David R. Thompson
- 7School of Nursing and Midwifery, Queen’s University Belfast, Belfast, United Kingdom
- Thomas Thum
- 9Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School and Fraunhofer Institute for Toxicology and Experimental Research, Hannover, Germany
- Emeline M. Van Craenenbroeck
- 2Research Group Cardiovascular Diseases, Genetics, Pharmacology and Physiopathology of Heart, Blood Vessels and Skeleton (GENCOR) Department, University of Antwerp, Antwerp, Belgium
- Emeline M. Van Craenenbroeck
- 3Department of Cardiology, Antwerp University Hospital, Edegem, Belgium
- DOI
- https://doi.org/10.3389/ti.2024.13191
- Journal volume & issue
-
Vol. 37
Abstract
Little is known either about either physical activity patterns, or other lifestyle-related prevention measures in heart transplantation (HTx) recipients. The history of HTx started more than 50 years ago but there are still no guidelines or position papers highlighting the features of prevention and rehabilitation after HTx. The aims of this scientific statement are (i) to explain the importance of prevention and rehabilitation after HTx, and (ii) to promote the factors (modifiable/non-modifiable) that should be addressed after HTx to improve patients’ physical capacity, quality of life and survival. All HTx team members have their role to play in the care of these patients and multidisciplinary prevention and rehabilitation programmes designed for transplant recipients. HTx recipients are clearly not healthy disease-free subjects yet they also significantly differ from heart failure patients or those who are supported with mechanical circulatory support. Therefore, prevention and rehabilitation after HTx both need to be specifically tailored to this patient population and be multidisciplinary in nature. Prevention and rehabilitation programmes should be initiated early after HTx and continued during the entire post-transplant journey. This clinical consensus statement focuses on the importance and the characteristics of prevention and rehabilitation designed for HTx recipients.
Keywords
